Replimune Group Inc
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG00L8Z22R1
REPL
Replimune Group Inc
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Biotechnology
NAME
Replimune Group Inc
ISIN
US76029N1063
TICKER
REPL
MIC
XNAS
REUTERS
REPL.OQ
BLOOMBERG
REPL US
F&G:
63
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Wed, 13.08.2025
Replimune Group
US76029N1063
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Replimune Group, Inc. (“Replimune”) (NASDAQ: REPL) on behalf of those who purchased or otherwise acquired Replimune securities between November 22, 2024, and July 21, 2025, inclusive (the “Class Peri...
Replimune Group
Fri, 25.07.2025
Replimune Group
US76029N1063
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) and certain of the Company’s senior executives for potential violations of the federal securities laws.
If you invested in Replimune, you are encouraged to obtain additional information by visiting: http...
Replimune Group
Fri, 25.07.2025
Replimune Group
US76029N1063
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Replimune Group, Inc. (“Replimune” or “the Company”) (NASDAQ: REPL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
...
Replimune Group
Thu, 24.07.2025
Replimune Group
US76029N1063
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Replimune investors under the federal sec...
Replimune Group
Tue, 22.07.2025
Replimune Group
US76029N1063
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. (“Replimune or the “Company”) (NASDAQ: REPL).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions o...
Replimune Group
Tue, 22.07.2025
Replimune Group
US76029N1063
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal securities laws.
If you invested in Replimune, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/replimune-group-class-a...
Replimune Group
Tue, 22.07.2025
Replimune Group
US76029N1063
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Replimune Group, Inc. (NASDAQ: REPL) resulting from allegations that Replimune may have issued materially misleading business information to the investing public.
So What: If you purchased Replimune secur...
Replimune Group
Information on product placements
BARRISTA SMART * AD
P R O D U C T S U G G E S T I O N S
